1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer, 2017. Available at https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed March 28, 2017.
2. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis;Senthi;Lancet Oncol,2012
3. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer;Fernando;J Thorac Cardiovasc Surg,2016
4. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials;Chang;Lancet Oncol,2015
5. American College of Surgeons. Facility oncology registry data standards, 2016. Available at https://www.facs.org/∼/media/files/quality%20programs/cancer/ncdb/fords%202016.ashx. Accessed March 28, 2017.